GNGBY
Price
$22.01
Change
-$0.07 (-0.32%)
Updated
Oct 2 closing price
Capitalization
6.12B
GRRMF
Price
$51.41
Change
-$0.24 (-0.46%)
Updated
Aug 5 closing price
Capitalization
1.54B
Interact to see
Advertisement

GNGBY vs GRRMF

Header iconGNGBY vs GRRMF Comparison
Open Charts GNGBY vs GRRMFBanner chart's image
Getinge AB
Price$22.01
Change-$0.07 (-0.32%)
Volume$640
Capitalization6.12B
Gerresheimer AG
Price$51.41
Change-$0.24 (-0.46%)
Volume$100
Capitalization1.54B
GNGBY vs GRRMF Comparison Chart in %
GNGBY
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
GNGBY vs. GRRMF commentary
Oct 06, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is GNGBY is a Hold and GRRMF is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Oct 06, 2025
Stock price -- (GNGBY: $22.01 vs. GRRMF: $51.41)
Brand notoriety: GNGBY and GRRMF are both not notable
GNGBY represents the Medical/Nursing Services, while GRRMF is part of the Pharmaceuticals: Other industry
Current volume relative to the 65-day Moving Average: GNGBY: 28% vs. GRRMF: 43%
Market capitalization -- GNGBY: $6.12B vs. GRRMF: $1.54B
GNGBY [@Medical/Nursing Services] is valued at $6.12B. GRRMF’s [@Pharmaceuticals: Other] market capitalization is $1.54B. The market cap for tickers in the [@Medical/Nursing Services] industry ranges from $234.25B to $0. The market cap for tickers in the [@Pharmaceuticals: Other] industry ranges from $162.16B to $0. The average market capitalization across the [@Medical/Nursing Services] industry is $5.58B. The average market capitalization across the [@Pharmaceuticals: Other] industry is $11.38B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

GNGBY’s FA Score shows that 2 FA rating(s) are green whileGRRMF’s FA Score has 0 green FA rating(s).

  • GNGBY’s FA Score: 2 green, 3 red.
  • GRRMF’s FA Score: 0 green, 5 red.
According to our system of comparison, GNGBY is a better buy in the long-term than GRRMF.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

GNGBY’s TA Score shows that 5 TA indicator(s) are bullish.

  • GNGBY’s TA Score: 5 bullish, 4 bearish.

Price Growth

GNGBY (@Medical/Nursing Services) experienced а +2.85% price change this week, while GRRMF (@Pharmaceuticals: Other) price change was 0.00% for the same time period.

The average weekly price growth across all stocks in the @Medical/Nursing Services industry was +2.81%. For the same industry, the average monthly price growth was +5.78%, and the average quarterly price growth was +19.30%.

The average weekly price growth across all stocks in the @Pharmaceuticals: Other industry was +4.63%. For the same industry, the average monthly price growth was +2.89%, and the average quarterly price growth was +20.22%.

Industries' Descriptions

@Medical/Nursing Services (+2.81% weekly)

The medical/nursing services includes companies that provide medical-related services such as ambulance services, dialysis centers, respiratory therapy, blood testing and rehabilitation services. DaVita Inc., Chemed Corporation and Guardant Health, Inc. are examples of companies in this industry.

@Pharmaceuticals: Other (+4.63% weekly)

Pharmaceuticals (Other) comprise companies that are involved in the discovery, development or manufacturing of therapeutic and preventative medicines. They often collaborate with or acquire other pharmaceutical/healthcare firms. Examples of companies in this segment include Bausch Health Companies Inc., Icon Plc and Perrigo Company Plc.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
GNGBY($6.12B) has a higher market cap than GRRMF($1.54B). GNGBY has higher P/E ratio than GRRMF: GNGBY (37.98) vs GRRMF (23.94). GNGBY YTD gains are higher at: 44.837 vs. GRRMF (-26.294). GNGBY has higher annual earnings (EBITDA): 5.51B vs. GRRMF (422M). GNGBY has more cash in the bank: 1.95B vs. GRRMF (203M). GRRMF has less debt than GNGBY: GRRMF (2.21B) vs GNGBY (11.2B). GNGBY has higher revenues than GRRMF: GNGBY (35.5B) vs GRRMF (2.19B).
GNGBYGRRMFGNGBY / GRRMF
Capitalization6.12B1.54B398%
EBITDA5.51B422M1,305%
Gain YTD44.837-26.294-171%
P/E Ratio37.9823.94159%
Revenue35.5B2.19B1,622%
Total Cash1.95B203M958%
Total Debt11.2B2.21B508%
FUNDAMENTALS RATINGS
GNGBY vs GRRMF: Fundamental Ratings
GNGBY
GRRMF
OUTLOOK RATING
1..100
5050
VALUATION
overvalued / fair valued / undervalued
1..100
15
Undervalued
54
Fair valued
PROFIT vs RISK RATING
1..100
86100
SMR RATING
1..100
8586
PRICE GROWTH RATING
1..100
4982
P/E GROWTH RATING
1..100
2348
SEASONALITY SCORE
1..100
5050

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

GNGBY's Valuation (15) in the null industry is somewhat better than the same rating for GRRMF (54). This means that GNGBY’s stock grew somewhat faster than GRRMF’s over the last 12 months.

GNGBY's Profit vs Risk Rating (86) in the null industry is in the same range as GRRMF (100). This means that GNGBY’s stock grew similarly to GRRMF’s over the last 12 months.

GNGBY's SMR Rating (85) in the null industry is in the same range as GRRMF (86). This means that GNGBY’s stock grew similarly to GRRMF’s over the last 12 months.

GNGBY's Price Growth Rating (49) in the null industry is somewhat better than the same rating for GRRMF (82). This means that GNGBY’s stock grew somewhat faster than GRRMF’s over the last 12 months.

GNGBY's P/E Growth Rating (23) in the null industry is in the same range as GRRMF (48). This means that GNGBY’s stock grew similarly to GRRMF’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
GNGBYGRRMF
RSI
ODDS (%)
Bearish Trend 3 days ago
61%
N/A
Stochastic
ODDS (%)
Bullish Trend 3 days ago
70%
N/A
Momentum
ODDS (%)
Bearish Trend 3 days ago
63%
N/A
MACD
ODDS (%)
Bearish Trend 3 days ago
58%
N/A
TrendWeek
ODDS (%)
Bullish Trend 3 days ago
69%
Bullish Trend 3 days ago
31%
TrendMonth
ODDS (%)
Bullish Trend 3 days ago
69%
Bullish Trend 3 days ago
28%
Advances
ODDS (%)
Bullish Trend 5 days ago
67%
N/A
Declines
ODDS (%)
Bearish Trend 11 days ago
58%
N/A
BollingerBands
ODDS (%)
Bullish Trend 3 days ago
77%
N/A
Aroon
ODDS (%)
Bullish Trend 3 days ago
65%
N/A
View a ticker or compare two or three
Interact to see
Advertisement
GNGBY
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
WXCRX15.930.15
+0.95%
William Blair Emerg Mkts ex China Gr R6
DODWX16.750.13
+0.78%
Dodge & Cox Global Stock I
GIXIX10.800.07
+0.65%
Nationwide International Index R6
DESGX26.040.05
+0.19%
DWS ESG Core Equity Institutional
PABAX17.53N/A
N/A
Putnam Dynamic Asset Allocation Bal A

GNGBY and

Correlation & Price change

A.I.dvisor tells us that GNGBY and CNMD have been poorly correlated (+32% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that GNGBY and CNMD's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To GNGBY
1D Price
Change %
GNGBY100%
N/A
CNMD - GNGBY
32%
Poorly correlated
+3.28%
ALGN - GNGBY
29%
Poorly correlated
+2.70%
AVNS - GNGBY
28%
Poorly correlated
+4.06%
SNN - GNGBY
27%
Poorly correlated
+0.47%
AEMD - GNGBY
26%
Poorly correlated
-0.58%
More

GRRMF and

Correlation & Price change

A.I.dvisor tells us that GRRMF and SAFLF have been poorly correlated (+21% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that GRRMF and SAFLF's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To GRRMF
1D Price
Change %
GRRMF100%
N/A
SAFLF - GRRMF
21%
Poorly correlated
N/A
GTHP - GRRMF
6%
Poorly correlated
-11.39%
GNGBY - GRRMF
4%
Poorly correlated
N/A
ICCM - GRRMF
3%
Poorly correlated
-2.63%
FZMD - GRRMF
1%
Poorly correlated
N/A
More